161
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Computational Simulations Reveal the Synergistic Action of Phytochemicals of Morus alba to Exert Anti-Alzheimer Activity via Inhibition of Acetylcholinesterase and Glycogen Synthase Kinase-3β

ORCID Icon, ORCID Icon, , , ORCID Icon & ORCID Icon
Pages 3476-3500 | Received 27 Jul 2022, Accepted 10 Jul 2023, Published online: 25 Jul 2023
 

Abstract

Morus alba Linn. is a popular medium-sized tree with a potent neuroprotective activity such as anti-Alzheimer. To date, it is not known which phytocompound of M. alba exerts anti-Alzheimer activity. Therefore, the present study was aimed to identify the phytochemicals of M. alba responsible for the anti-Alzheimer activity by targeting proteins such as acetylcholinesterase (AChE) and glycogen synthase kinase-3 beta (GSK-3β) that are associated in the pathogenesis of Alzheimer disease (AD). Molecular docking, molecular dynamics (MD) simulations and MM-GBSA calculations were performed for the study. Phytocompounds with code 32, 41, 67, and 70 showed the best glide gscore against AchE and GSK-3β. All these phytocompounds interacted with multiple crucial amino acids present at the active binding site of the proteins through conventional hydrogen bonds and hydrophobic interactions. MD simulations of 100 ns revealed stable conformation for all protein-ligand complexes. Based on the computational findings, we conclude that M. alba’s phytoconstituents (32, 41 67, and 70) exerts anti-Alzheimer potential by inhibiting AChE and GSK-3β.

Acknowledgments

Special thanks to the Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, JH (India) for providing high-performance computing for carrying out molecular dynamics simulations.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The authors thank BIT Mesra, Ranchi, and Ankara University-Scientific Research Unit for supplying the Schrödinger software purchased under grant project [number BAP-21B0237004].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.